Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.00 HKD | 0.00% | -6.54% | +56.49% |
08-23 | China Hongqiao Group to Gain From Strong Industry Conditions, But Short-Term Debt Reliance a Key Weakness, S&P Says | MT |
08-19 | China Hongqiao Group's H1 Attributable Profit Soars 273% | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 84.18B | 86.14B | 114B | 132B | 134B | |||||
Total Revenues | 84.18B | 86.14B | 114B | 132B | 134B | |||||
Cost of Goods Sold, Total | 67.74B | 66.81B | 84.13B | 114B | 113B | |||||
Gross Profit | 16.44B | 19.34B | 30.36B | 18.16B | 20.84B | |||||
Selling General & Admin Expenses, Total | 4.09B | 4.45B | 6.23B | 6.53B | 5.71B | |||||
Other Operating Expenses | 15.85M | 17.48M | 756K | 82K | 620K | |||||
Other Operating Expenses, Total | 4.11B | 4.47B | 6.23B | 6.53B | 5.71B | |||||
Operating Income | 12.33B | 14.87B | 24.13B | 11.62B | 15.13B | |||||
Interest Expense, Total | -5.22B | -4.51B | -3.63B | -3.02B | -3.27B | |||||
Interest And Investment Income | 420M | 621M | 731M | 701M | 1.02B | |||||
Net Interest Expenses | -4.8B | -3.89B | -2.89B | -2.32B | -2.24B | |||||
Income (Loss) On Equity Invest. | 509M | 515M | 61.52M | 503M | 1.19B | |||||
Currency Exchange Gains (Loss) | - | 321M | 394M | - | - | |||||
Other Non Operating Income (Expenses) | 1.42B | 1.38B | 2.26B | 3.16B | 2.54B | |||||
EBT, Excl. Unusual Items | 9.45B | 13.2B | 23.95B | 12.97B | 16.62B | |||||
Merger & Related Restructuring Charges | -240K | - | -580K | - | - | |||||
Impairment of Goodwill | - | -331M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | -117M | -185M | 21.05M | |||||
Gain (Loss) On Sale Of Assets | 401M | 1.41M | - | 22.78M | 69.94M | |||||
Asset Writedown | -762M | -162M | -1.39B | -225M | -818M | |||||
Insurance Settlements | 153M | - | - | - | - | |||||
Other Unusual Items | -476M | - | 107M | 20.52M | - | |||||
EBT, Incl. Unusual Items | 8.77B | 12.7B | 22.55B | 12.61B | 15.89B | |||||
Income Tax Expense | 2.32B | 2.26B | 5.71B | 2.8B | 3.39B | |||||
Earnings From Continuing Operations | 6.46B | 10.44B | 16.85B | 9.81B | 12.5B | |||||
Net Income to Company | 6.46B | 10.44B | 16.85B | 9.81B | 12.5B | |||||
Minority Interest | -360M | 51.18M | -775M | -1.11B | -1.04B | |||||
Net Income - (IS) | 6.1B | 10.5B | 16.07B | 8.7B | 11.46B | |||||
Net Income to Common Incl Extra Items | 6.1B | 10.5B | 16.07B | 8.7B | 11.46B | |||||
Net Income to Common Excl. Extra Items | 6.1B | 10.5B | 16.07B | 8.7B | 11.46B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.71 | 1.22 | 1.77 | 0.94 | 1.21 | |||||
Basic EPS - Continuing Operations | 0.71 | 1.22 | 1.77 | 0.94 | 1.21 | |||||
Basic Weighted Average Shares Outstanding | 8.6B | 8.6B | 9.07B | 9.3B | 9.48B | |||||
Net EPS - Diluted | 0.7 | 1.22 | 1.71 | 0.94 | 1.2 | |||||
Diluted EPS - Continuing Operations | 0.7 | 1.22 | 1.71 | 0.94 | 1.2 | |||||
Diluted Weighted Average Shares Outstanding | 8.86B | 8.6B | 9.66B | 9.3B | 9.8B | |||||
Normalized Basic EPS | 0.65 | 0.97 | 1.56 | 0.75 | 0.99 | |||||
Normalized Diluted EPS | 0.63 | 0.97 | 1.47 | 0.75 | 0.95 | |||||
Dividend Per Share | 0.3 | 0.55 | 0.86 | 0.45 | 0.37 | |||||
Payout Ratio | 31.52 | 35.9 | 44.7 | 102.51 | 38.12 | |||||
American Depositary Receipts Ratio (ADR) | 10 | 10 | 10 | 10 | 10 | |||||
Supplemental Items | ||||||||||
EBITDA | 19.55B | 21.56B | 30.65B | 18.4B | 22.09B | |||||
EBITA | 12.33B | 14.87B | 24.13B | 11.63B | 15.13B | |||||
EBIT | 12.33B | 14.87B | 24.13B | 11.62B | 15.13B | |||||
EBITDAR | 19.55B | - | 30.68B | - | - | |||||
Effective Tax Rate - (Ratio) | 26.4 | 17.79 | 25.3 | 22.19 | 21.35 | |||||
Current Domestic Taxes | - | 2.84B | 5.39B | - | - | |||||
Current Foreign Taxes | - | 39.55M | 137M | - | - | |||||
Total Current Taxes | 2.48B | 2.88B | 5.52B | 3.09B | 3.94B | |||||
Total Deferred Taxes | -168M | -623M | 183M | -291M | -545M | |||||
Normalized Net Income | 5.55B | 8.3B | 14.2B | 7B | 9.35B | |||||
Interest Capitalized | - | - | 128M | 415M | 563M | |||||
Interest on Long-Term Debt | 3.24B | 2.68B | 1.91B | 1.19B | 1.12B | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 449M | 400M | 526M | 598M | 755M | |||||
General and Administrative Expenses | 3.65B | 4.05B | 5.71B | 5.93B | 4.95B | |||||
Research And Development Expense From Footnotes | 800M | 703M | 851M | 986M | 1.01B | |||||
Net Rental Expense, Total | 176K | - | 25.94M | - | - | |||||
Imputed Operating Lease Interest Expense | 91.19K | - | 11.52M | - | - | |||||
Imputed Operating Lease Depreciation | 84.81K | - | 14.43M | - | - |